Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetyl cysteine versus placebo for acute radicular lumbar pain
IRCT20120215009014N381Phase 3Completed
- Sponsor
- Hamadan University of Medical Sciences
- Start
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in lumbosacral radiculopathy and herniated disc comparing Routine treatment + N-acetyl cysteine with Routine treatment + placebo (2 arms). Primary endpoints: Functional disability, Pain severity and 1 more. Started May 2021; status: completed.
02
Drugs
acetylcysteine
03
Conditions
lumbosacral radiculopathyherniated disc
Beyond the preview
Go deeper on IRCT20120215009014N381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120215009014N381.